Literature DB >> 9469646

Relevance of irinotecan hydrochloride-induced diarrhea to the level of prostaglandin E2 and water absorption of large intestine in rats.

Y Kase1, T Hayakawa, Y Togashi, T Kamataki.   

Abstract

For characterization of the mechanism(s) of severe diarrhea due to the anticancer agent, irinotecan hydrochloride (CPT-11), examination was made of the relation of CPT-11-related diarrhea to colonic prostaglandin E2 (PGE2) and water absorption in rats. Acute diarrheal symptoms were observed within 1 hr after the administration of CPT-11 to rats, with increased PGE2 and decreased water absorption in the colon. Treatment with atropine at 1 mg/kg, s.c. was noted to inhibit intestinal PGE2 and the CPT-11-related acute diarrheal symptoms, indicating that these diarrheal symptoms were mediated through the cholinergic nervous system accelerated functionally by CPT-11. On the other hand, daily treatment of CPT-11 at the same dose resulted in chronic diarrheal symptoms in all animals 3 days after CPT-11 treatment. Histopathological changes observed in the descending colon and ileum of the rats included degeneration and necrosis of villi and cryptal cells and a decrease in the number of the goblet cells. Significantly increased PGE2 and impaired water absorption of the descending colon were also observed during the chronic diarrheal stage. It can be considered that the chronic diarrheal symptoms appear as a consequence of the gastrointestinal injury characterized by significant increase in PGE2 accompanied by impaired water absorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9469646     DOI: 10.1254/jjp.75.399

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  12 in total

1.  A novel genetic score model of UGT1A1 and TGFB pathway as predictor of severe irinotecan-related diarrhea in metastatic colorectal cancer patients.

Authors:  Jing Li; Qianqian Yu; Shengling Fu; Min Xu; Tao Zhang; Conghua Xie; Jueping Feng; Jigui Chen; Aihua Zang; Yixin Cai; Qiang Fu; Shan Liu; Mingsheng Zhang; Qiu Hong; Liu Huang; Xianglin Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-09       Impact factor: 4.553

2.  Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents.

Authors:  K Arimori; N Kuroki; A Kumamoto; N Tanoue; M Nakano; E Kumazawa; A Tohgo; M Kikuchi
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Authors:  Umang Swami; Sanjay Goel; Sridhar Mani
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

5.  Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats.

Authors:  Marina Fittkau; Wieland Voigt; Hans-Jürgen Holzhausen; Hans-Joachim Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

6.  Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.

Authors:  W E Hardman; M P Moyer; I L Cameron
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice.

Authors:  W E Hardman; M P Moyer; I L Cameron
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

Review 8.  Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments.

Authors:  Rachel M McQuade; Vanesa Stojanovska; Raquel Abalo; Joel C Bornstein; Kulmira Nurgali
Journal:  Front Pharmacol       Date:  2016-11-03       Impact factor: 5.810

9.  Alleviation of Abdominal Pain due to Irinotecan-Induced Cholinergic Syndrome Using Loperamide: A Case Report.

Authors:  Kazuki Uchiyama; Yoshitaka Saito; Yoh Takekuma; Satoshi Yuki; Mitsuru Sugawara
Journal:  Case Rep Oncol       Date:  2021-06-10

10.  The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.

Authors:  Deysi V T Wong; Roberto C P Lima-Júnior; Cibele B M Carvalho; Vanessa F Borges; Carlos W S Wanderley; Amanda X C Bem; Caio A V G Leite; Maraiza A Teixeira; Gabriela L P Batista; Rangel L Silva; Thiago M Cunha; Gerly A C Brito; Paulo R C Almeida; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.